352 related articles for article (PubMed ID: 28339389)
1. Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments.
Allen LV
Int J Pharm Compd; 2016; 20(6):495-500. PubMed ID: 28339389
[TBL] [Abstract][Full Text] [Related]
2. Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions.
Allen LV
Int J Pharm Compd; 2016; 20(5):399-404. PubMed ID: 28339375
[TBL] [Abstract][Full Text] [Related]
3. Sterile Product Packaging and Delivery Systems.
Akers MJ
Int J Pharm Compd; 2015; 19(6):491-500. PubMed ID: 26891564
[TBL] [Abstract][Full Text] [Related]
4. Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms.
Akers MJ
Int J Pharm Compd; 2017; 21(1):47-56. PubMed ID: 28346198
[TBL] [Abstract][Full Text] [Related]
5. Choosing a Vial Processing Line for Aseptic Compounding: Part 1.
Noorian S; Vahedi N
Int J Pharm Compd; 2016; 20(4):283-292. PubMed ID: 28333673
[TBL] [Abstract][Full Text] [Related]
6. Basics of compounding: tips and hints, Part 3: compounding with ointments, creams, pastes, gels, and gel-creams.
Allen LV
Int J Pharm Compd; 2014; 18(3):228-30. PubMed ID: 25306771
[TBL] [Abstract][Full Text] [Related]
7. Sterile ophthalmic ointment and suspension manufacturing.
Abshire R; Cash P
J Parenter Sci Technol; 1986; 40(3):97-9. PubMed ID: 3746580
[No Abstract] [Full Text] [Related]
8. Perspectives on Physicochemical and In Vitro Profiling of Ophthalmic Ointments.
Bao Q; Burgess DJ
Pharm Res; 2018 Oct; 35(12):234. PubMed ID: 30324424
[TBL] [Abstract][Full Text] [Related]
9. Basics of Compounding: Compounding Films.
Allen LV
Int J Pharm Compd; 2016; 20(4):298-305. PubMed ID: 28333675
[TBL] [Abstract][Full Text] [Related]
10. [Prescription preparation of microbially uncontaminated eyedrops eye ointments. 3].
Frauch P
Pharm Acta Helv; 1970 Jun; 45(6):329-44. PubMed ID: 5426097
[No Abstract] [Full Text] [Related]
11. Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding.
Akers MJ
Int J Pharm Compd; 2016; 20(4):307-314. PubMed ID: 28333676
[TBL] [Abstract][Full Text] [Related]
12. Ophthalmic ointments.
Robin JS; Ellis PP
Surv Ophthalmol; 1978; 22(5):335-40. PubMed ID: 653578
[TBL] [Abstract][Full Text] [Related]
13. [Preparation of eyedrops under field conditions].
Khveshuk PF; Stepanov AA; Voronkov OV; Riabykh LD
Voen Med Zh; 1978 Oct; (10):83-4. PubMed ID: 360603
[No Abstract] [Full Text] [Related]
14. Does your pharmacy have a compounding isolator?
LaBella CJ
Am J Health Syst Pharm; 2007 Apr; 64(8):855-8. PubMed ID: 17420203
[No Abstract] [Full Text] [Related]
15. Contamination Control.
Akers MJ
Int J Pharm Compd; 2015; 19(3):232-8. PubMed ID: 26714364
[TBL] [Abstract][Full Text] [Related]
16. Quality Assurance and Quality Control, Part 2.
Akers MJ
Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362
[TBL] [Abstract][Full Text] [Related]
17. Basics of sterile compounding: compounding by weight versus compounding by volume.
Thoma L
Int J Pharm Compd; 2014; 18(2):131-4. PubMed ID: 24881117
[TBL] [Abstract][Full Text] [Related]
18. Formulation and Stability of Solutions.
Akers MJ
Int J Pharm Compd; 2016; 20(1):41-5. PubMed ID: 27127830
[TBL] [Abstract][Full Text] [Related]
19. [Considerations for the control of ophthalmic tubes with aluminum varnish].
Herman F; Aerts A; Alexis J; Barbe ; Baudon P; Delattre L; Leloup J; Stein E; Van den Eeckhout E
J Pharm Belg; 1972; 27(4):480-92. PubMed ID: 4681078
[No Abstract] [Full Text] [Related]
20. Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.
Peters GF; McKeon MR; Weiss WT
Am J Health Syst Pharm; 2007 Mar; 64(6):622-31. PubMed ID: 17353571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
